Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy

[1]  U. Zeymer,et al.  Abstract 16661: Impact of Age on Procedural Success Rates and Inhospital Outcomes in Patients With PCI for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Results of the Alkk-PCI-registry , 2016 .

[2]  G. Schuler,et al.  Impairment of the Endothelial Glycocalyx in Cardiogenic Shock and its Prognostic Relevance , 2015, Shock.

[3]  M. Kuiper,et al.  Microcirculatory perfusion and vascular reactivity are altered in post cardiac arrest patients, irrespective of target temperature management to 33 °C vs 36 °C. , 2015, Resuscitation.

[4]  G. Schuler,et al.  Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial , 2014, Clinical Research in Cardiology.

[5]  E. Andrinopoulou,et al.  Early microcirculatory impairment during therapeutic hypothermia is associated with poor outcome in post-cardiac arrest children: a prospective observational cohort study. , 2014, Resuscitation.

[6]  G. Schuler,et al.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial , 2013, The Lancet.

[7]  E. Adrario,et al.  From Macrohemodynamic to the Microcirculation , 2013, Critical care research and practice.

[8]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[9]  S. Cook,et al.  Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock: Results of the Impella–EUROSHOCK-Registry , 2013, Circulation. Heart failure.

[10]  H. Figulla,et al.  Increased arginase levels in heart failure represent a therapeutic target to rescue microvascular perfusion. , 2013, Clinical hemorheology and microcirculation.

[11]  Deepak L. Bhatt,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[12]  J. Brachmann,et al.  Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry , 2013, Clinical Research in Cardiology.

[13]  G. Schuler,et al.  Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.

[14]  N. Danchin,et al.  Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. , 2012, European heart journal.

[15]  G. Schuler,et al.  Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. , 2012, American heart journal.

[16]  J. Haerting,et al.  Hemodynamic Effects of Intra-aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock: The Prospective, Randomized IABP Shock Trial , 2012, Shock.

[17]  P. Loyalka,et al.  The percutaneous ventricular assist device in severe refractory cardiogenic shock. , 2011, Journal of the American College of Cardiology.

[18]  M. Simoons,et al.  Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. , 2010, European heart journal.

[19]  C. Jung,et al.  Microcirculation in cardiogenic shock: from scientific bystander to therapy target , 2010, Critical care.

[20]  C. Ince,et al.  Withdrawing intra-aortic balloon pump support paradoxically improves microvascular flow , 2010, Critical care.

[21]  J. Vincent,et al.  Monitoring the microcirculation in the critically ill patient: current methods and future approaches , 2010, Intensive Care Medicine.

[22]  G. Chatellier,et al.  Shock in acute myocardial infarction: the Cape Horn for trials? , 2010, European heart journal.

[23]  S. Werns.  A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? , 2010 .

[24]  H. Figulla,et al.  Effect of intra-aortic balloon pump support on microcirculation during high-risk percutaneous intervention , 2009, Perfusion.

[25]  P. Serruys,et al.  Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. , 2009, European heart journal.

[26]  H. Figulla,et al.  Acute microflow changes after stop and restart of intra-aortic balloon pump in cardiogenic shock , 2009, Clinical Research in Cardiology.

[27]  M. Simoons,et al.  The Effects of Intra-Aortic Balloon Pump Support on Macrocirculation and Tissue Microcirculation in Patients with Cardiogenic Shock , 2009, Cardiology.

[28]  M. Simoons,et al.  Low‐dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure , 2009, European journal of heart failure.

[29]  C. Jung,et al.  Evaluation of the sublingual microcirculation in cardiogenic shock. , 2009, Clinical hemorheology and microcirculation.

[30]  J. Bakker,et al.  The heterogeneity of the microcirculation in critical illness. , 2008, Clinics in chest medicine.

[31]  H. Figulla,et al.  Combined Impella and intra-aortic ballon pump support to improve macro- and microcirculation: a clinical case , 2008, Clinical Research in Cardiology.

[32]  J. Parrillo,et al.  Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis , 2008, Intensive Care Medicine.

[33]  C. Jung,et al.  Evaluation of the microcirculation during extracorporeal membrane-oxygenation. , 2008, Clinical hemorheology and microcirculation.

[34]  G. Ospina-Tascón,et al.  How to evaluate the microcirculation: report of a round table conference , 2007, Critical care.

[35]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[36]  J. Vincent,et al.  Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. , 2004, American heart journal.

[37]  Allison Jordan.  Death and Life are in the Power of the Tongue , 2003 .

[38]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[39]  R. Califf,et al.  Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. , 1999, American heart journal.

[40]  M. Rubenfire,et al.  Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. , 1973, The New England journal of medicine.